Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Metabolyz vs Modern Age

Metabolyz
Graded #339

Higher grade

vs+0.8999999999999986
Modern Age
Graded #362

Lower grade

The verdict

Metabolyz takes it — 59.6/100 to 58.7/100, but only just.

Metabolyz grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Metabolyz is a nationwide GLP-1 telehealth platform offering three compounded programs — standard semaglutide, dual-agonist tirzepatide, and a microdose protocol for patients near goal weight or intolerant… Modern Age is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationModern Age +13
40
53
Clinical oversightModern Age +2
81
83
Labs & monitoringModern Age +14
63
77
FulfillmentMetabolyz +27
86
59
Contract termsMetabolyz +35
55
20
Metabolyz · left barModern Age · right bar

The numbers

MetricMetabolyzModern Age
WeighScore59.6/10058.7/100
GradeCC
Scorecard rank#339#362
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Metabolyz

Graded #339 · C

Strengths

  • Three GLP-1 programs: standard semaglutide, dual-agonist tirzepatide, and a microdose protocol for near-goal or dose-sensitive patients
  • Nutrition, movement, and lifestyle coaching included in all programs at no extra charge
  • Medication compounded in licensed 503A/503B US pharmacies with temperature-controlled, unmarked direct-to-door delivery
  • Licensed provider supervision with direct messaging access and structured check-ins throughout
  • Telehealth across all 50 states; BMI 27+ eligibility (25+ with weight-related condition)

Where it loses points

  • Pricing is fully gated — not disclosed until after consultation, preventing upfront cost comparison
  • Compounded GLP-1 only — no brand-name options (Wegovy, Zepbound) available
  • No LegitScript certification or named medical leadership found on public-facing pages
  • Labs not mentioned as included — unclear whether baseline or follow-up bloodwork is offered
  • Newer brand with no external reviews, published outcomes data, or notable accreditations
Modern Age

Graded #362 · C

Strengths

  • Uses FDA-approved branded GLP-1 medication (Wegovy/Ozempic), no compounding
  • Comprehensive assessment with labs, at-home tests and clinician review
  • Board-certified clinicians and structured 6-month program
  • Longevity-oriented, whole-person approach beyond weight loss

Where it loses points

  • Expensive: $500 assessment plus $500 program, with medication billed separately
  • Branded GLP-1 can cost $900-1600/mo if not covered by insurance
  • Only available in 16 states (specific states not listed publicly)
  • Premium positioning makes it costlier than compounded-subscription rivals

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard